Related Experiment Video
Updated: May 7, 2025

12:24
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.0K
Do Risk Factors for HCC Impact the Association of CT/MRI LIRADS Major Features With HCC? An Individual Participant
Robert G Adamo1, Eric Lam2, Jean-Paul Salameh1
1Faculty of Medicine at The University of Ottawa, Ottawa, ON, Canada.
Summary
The Liver Imaging Reporting and Data System (LI-RADS) major features are consistently associated with hepatocellular carcinoma (HCC) risk across various patient factors. This suggests LI-RADS can be applied universally to at-risk populations without modification.
Area of Science:
- Radiology and Medical Imaging
- Hepatology
- Oncology
Background:
- Guidelines suggest Liver Imaging Reporting and Data System (LI-RADS) applicability may vary in certain hepatocellular carcinoma (HCC) risk populations.
- Limited data exist on the association between HCC risk factors and LI-RADS major features.
- This study addresses the gap by evaluating these associations.
Purpose of the Study:
- To determine if the association between HCC risk factors and CT/MRI LI-RADS major features differs among individuals at risk for HCC.
- To provide evidence for the universal application of LI-RADS in at-risk populations.
Main Methods:
- A systematic search of multiple databases (MEDLINE, Embase, Cochrane, Scopus) from 2014-2022.
- Individual participant data (IPD) meta-regression analysis of 23 studies (2958 patients).
- Assessment of interactions between LI-RADS major features and HCC risk factors (age, sex, cirrhosis, HBV).
Main Results:
- The association between LI-RADS major features and HCC was consistent across various HCC risk factors.
- P-values ranged from 0.09 to 0.99, indicating no significant differences.
- Sensitivity analysis of low-bias studies confirmed primary findings.
Conclusions:
- CT/MRI LI-RADS major features' association with HCC risk factors does not significantly differ in at-risk individuals.
- CT/MR LI-RADS should be applied to all patients deemed at risk by the system, without modification.
- Findings support the standardized use of LI-RADS for HCC risk assessment.
Related Concept Videos
Hazard Ratio
62
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
62
lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K

